EP1023045A2 - Verabreichungsträger für bioaktiven wirkstoffen und ihre verwendung - Google Patents

Verabreichungsträger für bioaktiven wirkstoffen und ihre verwendung

Info

Publication number
EP1023045A2
EP1023045A2 EP98955098A EP98955098A EP1023045A2 EP 1023045 A2 EP1023045 A2 EP 1023045A2 EP 98955098 A EP98955098 A EP 98955098A EP 98955098 A EP98955098 A EP 98955098A EP 1023045 A2 EP1023045 A2 EP 1023045A2
Authority
EP
European Patent Office
Prior art keywords
composition
oil
nucleic acid
bioactive agent
surface active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98955098A
Other languages
English (en)
French (fr)
Inventor
Lawrence L. Kunz
Thomas R. Tice
Randell T. Libby
Christopher W. Mcdaniel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Southern Research Institute
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of EP1023045A2 publication Critical patent/EP1023045A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
EP98955098A 1997-10-24 1998-10-23 Verabreichungsträger für bioaktiven wirkstoffen und ihre verwendung Withdrawn EP1023045A2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6311497P 1997-10-24 1997-10-24
US95669497A 1997-10-24 1997-10-24
US956694 1997-10-24
US63114P 1997-10-24
PCT/US1998/022552 WO1999021533A2 (en) 1997-10-24 1998-10-23 Delivery vehicles for bioactive agents and uses thereof

Publications (1)

Publication Number Publication Date
EP1023045A2 true EP1023045A2 (de) 2000-08-02

Family

ID=26743057

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98955098A Withdrawn EP1023045A2 (de) 1997-10-24 1998-10-23 Verabreichungsträger für bioaktiven wirkstoffen und ihre verwendung

Country Status (4)

Country Link
EP (1) EP1023045A2 (de)
AU (1) AU1198599A (de)
CA (1) CA2306090A1 (de)
WO (1) WO1999021533A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200957B1 (en) * 1995-12-14 2001-03-13 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
IT1318539B1 (it) 2000-05-26 2003-08-27 Italfarmaco Spa Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
US20020155084A1 (en) * 2000-06-02 2002-10-24 The Regents Of The University Of The Michigan Nanoemulsion formulations
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
PL1787658T3 (pl) * 2005-11-10 2012-08-31 Italfarmaco Spa Formulacje o przedłużonym uwalnianiu analogów somatostatyny będących inhibitorami hormonu wzrostu
AU2014209218B2 (en) 2013-01-25 2018-06-07 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
CN111394444A (zh) * 2013-09-13 2020-07-10 生命技术公司 使用凝聚核酸颗粒的装置制备
WO2017223199A1 (en) * 2016-06-22 2017-12-28 Xcell Biosciences, Inc. Methods for increasing cell culture transfection efficiency and cellular reprogramming

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171125A (en) * 1966-06-08 1969-11-19 Glaxo Lab Ltd Improvements in or relating to Injectable Preparations
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
TW283648B (de) * 1993-01-21 1996-08-21 Yamanouchi Pharma Co Ltd
WO1995011700A1 (en) * 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9921533A3 *

Also Published As

Publication number Publication date
AU1198599A (en) 1999-05-17
WO1999021533A3 (en) 1999-07-08
WO1999021533A2 (en) 1999-05-06
CA2306090A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
US20020169138A1 (en) Delivery vehicles for bioactive agents and uses thereof
DE69736432T2 (de) Hemmung der bcl-2 protein expression durch liposomale antisense-oligodeoxynukleotide
Koo et al. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis
US8333959B2 (en) Ex-vivo application of solid microparticulate therapeutic agents
ES2682421T3 (es) Agente para tratar la mielofibrosis
KR101948839B1 (ko) 음이온성 약물 함유 약제학적 조성물 및 그 제조방법
WO2021021634A1 (en) Nanomaterials containing constrained lipids and uses thereof
TW201124425A (en) Parenteral formulations of gemcitabine derivatives
KR20090130081A (ko) 2상 지질-소포 조성물 및 질내 송달에 의한 자궁경부 이형성증의 치료 방법
WO2019212288A1 (ko) Messenger rna 전달용 고분자 나노입자 조성물 및 그 제조방법
CN106659683A (zh) 包封修饰的环糊精复合物的脂质体组合物及其应用
EP1023045A2 (de) Verabreichungsträger für bioaktiven wirkstoffen und ihre verwendung
CA2559352A1 (en) Lipid compositions and use thereof
Dreaden et al. RNA‐peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors
US20200368174A1 (en) Particles for targeted delivery of active agents into adipose stromal cells
NZ518799A (en) Delivery vehicles for bioactive agents comprising oil in water
DE69736290T2 (de) Hemmung des wachstums der chronischen myelogenen leukämischen zellen durch antisens-oligonukleotide die an grb2 zielgerichtet sind
WO1991007973A1 (fr) Emulsion grasse
KR101949507B1 (ko) Kras를 표적으로 하는 핵산 함유 약제학적 조성물 및 그 제조방법
WO2023054241A1 (ja) 核酸を脳組織に送達するために用いられる脂質ナノ粒子
WO2007014150A2 (en) Method of administering liposomes containing oligonucleotides
WO2023054242A1 (ja) 核酸をリンパ管内皮細胞に送達するために用いられる脂質ナノ粒子
WO2017097197A1 (zh) 美西替康的药物组合物
US20230310647A1 (en) Targeting cartilage egfr pathway for osteoarthritis treatment
KR20220149400A (ko) 이황화 결합을 갖는 양이온성 지질을 사용하여 약물을 전달하기 위한 나노입자 조성물 및 그 제조방법

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000522

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SOUTHERN RESEARCH INSTITUTE

Owner name: NEORX CORPORATION

17Q First examination report despatched

Effective date: 20020610

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031202

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1030877

Country of ref document: HK